Business Segments · Capital expenditures, gross
Diagnostics — Capital expenditures, gross
Danaher Diagnostics — Capital expenditures, gross decreased by 26.2% to $144M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.2%, from $115M to $144M. Over 2 years (FY 2023 to FY 2025), Diagnostics — Capital expenditures, gross shows relatively stable performance with a 4.1% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2023
Last reportedQ1 2026Apr 21, 2026
Rolls up toProperty, plant, and equipment additions
How to read this metric
Higher spending suggests investment in growth or maintenance, while very low spending may indicate under-investment in the business.
Detailed definition
The total cash outflow for the acquisition or maintenance of physical assets, such as manufacturing machinery and labora...
Peer comparison
Standard metric for capital-intensive manufacturing and life science firms.
Metric ID:
dhr_segment_diagnostics_capital_expenditures_grossHistorical Data
13 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $136.5M | $136.5M | $136.5M | $136.5M | $127M | $126M | $129M | $168M | $115M | $125M | $157M | $195M | $144M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -7.0% | -0.8% | +2.4% | +30.2% | -31.5% | +8.7% | +25.6% | +24.2% | -26.2% |
| YoY Change | — | — | — | — | -7.0% | -7.7% | -5.5% | +23.1% | -9.4% | -0.8% | +21.7% | +16.1% | +25.2% |
Range$115M – $195M
CAGR+1.8%
Avg YoY Growth+6.2%
Median YoY Growth-0.8%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's diagnostics — capital expenditures, gross?
- Danaher (DHR) reported diagnostics — capital expenditures, gross of $144M in Q1 2026.
- How has Danaher's diagnostics — capital expenditures, gross changed year-over-year?
- Danaher's diagnostics — capital expenditures, gross increased by 25.2% year-over-year, from $115M to $144M.
- What is the long-term trend for Danaher's diagnostics — capital expenditures, gross?
- Over 2 years (2023 to 2025), Danaher's diagnostics — capital expenditures, gross has grown at a 4.1% compound annual growth rate (CAGR), from $546M to $592M.
- What does diagnostics — capital expenditures, gross mean?
- Total spending on physical assets to support the diagnostics business.